The expression of GHRH has been demonstrated in prostatic, endometrial, ovarian, breast, gastroenteropatic, and lung carcinomas, glioblastomas, malignant bone tumors, human adrenal carcinomas and colorectal cancers (8). Here, GHRH is linked to glioblastoma.